Edward W Frykman - Net Worth and Insider Trading
Edward W Frykman Net Worth
The estimated net worth of Edward W Frykman is at least $230,514 dollars as of 2025-03-23. Edward W Frykman is the Director of Acacia Research Corp and owns about 45,757 shares of Acacia Research Corp (ACTG) stock worth over $156,489. Edward W Frykman is also the Director of Arrowhead Pharmaceuticals Inc and owns about 5,000 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $74,025. Details can be seen in Edward W Frykman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Edward W Frykman has not made any transactions after 2010-12-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Edward W Frykman
Edward W Frykman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Edward W Frykman owns 2 companies in total, including Arrowhead Pharmaceuticals Inc (ARWR) , and Acacia Research Corp (ACTG) .
Click here to see the complete history of Edward W Frykman’s form 4 insider trades.
Insider Ownership Summary of Edward W Frykman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARWR | Arrowhead Pharmaceuticals Inc | 2004-01-30 | director |
| ACTG | Acacia Research Corp | 2010-12-08 | director |
Edward W Frykman Latest Holdings Summary
Edward W Frykman currently owns a total of 2 stocks. Among these stocks, Edward W Frykman owns 45,757 shares of Acacia Research Corp (ACTG) as of December 8, 2010, with a value of $156,489 and a weighting of 67.89%. Edward W Frykman also owns 5,000 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of January 30, 2004, with a value of $74,025 and a weighting of 32.11%.
Latest Holdings of Edward W Frykman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACTG | Acacia Research Corp | 2010-12-08 | 45,757 | 3.42 | 156,489 |
| ARWR | Arrowhead Pharmaceuticals Inc | 2004-01-30 | 5,000 | 14.81 | 74,025 |
Holding Weightings of Edward W Frykman
Edward W Frykman Form 4 Trading Tracker
According to the SEC Form 4 filings, Edward W Frykman has made a total of 0 transactions in Acacia Research Corp (ACTG) over the past 5 years. The most-recent trade in Acacia Research Corp is the sale of 27,400 shares on December 8, 2010, which brought Edward W Frykman around $801,998.
According to the SEC Form 4 filings, Edward W Frykman has made a total of 0 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 0 shares on January 30, 2004, which brought Edward W Frykman around $0.
Insider Trading History of Edward W Frykman
- 1
Edward W Frykman Trading Performance
Edward W Frykman Ownership Network
Ownership Network List of Edward W Frykman
Ownership Network Relation of Edward W Frykman
Edward W Frykman Owned Company Details
What does Arrowhead Pharmaceuticals Inc do?
Who are the key executives at Arrowhead Pharmaceuticals Inc?
Edward W Frykman is the director of Arrowhead Pharmaceuticals Inc. Other key executives at Arrowhead Pharmaceuticals Inc include director & President and CEO Christopher Richard Anzalone , CFO Kenneth Allen Myszkowski , and General Counsel Patrick O'brien .
Arrowhead Pharmaceuticals Inc (ARWR) Insider Trades Summary
Over the past 18 months, Edward W Frykman made no insider transaction in Arrowhead Pharmaceuticals Inc (ARWR). Other recent insider transactions involving Arrowhead Pharmaceuticals Inc (ARWR) include a net sale of 506,009 shares made by Christopher Richard Anzalone , a net sale of 85,112 shares made by James C Hamilton , and a net sale of 17,063 shares made by Victoria Vakiener .
In summary, during the past 3 months, insiders sold 481,834 shares of Arrowhead Pharmaceuticals Inc (ARWR) in total and bought 0 shares, with a net sale of 481,834 shares. During the past 18 months, 844,143 shares of Arrowhead Pharmaceuticals Inc (ARWR) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 841,143 shares.
Arrowhead Pharmaceuticals Inc (ARWR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arrowhead Pharmaceuticals Inc Insider Transactions
Edward W Frykman Mailing Address
Above is the net worth, insider trading, and ownership report for Edward W Frykman. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Edward W Frykman's mailing address is: Los Angeles Ca 90017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
